Pure Global

Alpha-1-antitrypsin (protease inhibitor) IVD, reagent - UK MHRA Medical Device Registration

Alpha-1-antitrypsin (protease inhibitor) IVD, reagent is a medical device registered with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) under Device ID 134335. The device is manufactured by KAMIYA BIOMEDICAL COMPANY, LLC from United States, classified as In Vitro Diagnostic Device. The authorized representative in the UK is Oxford Biosystems Ltd.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, device classification, authorized representative details, and related products. Pure Global AI offers free access to 150,962+ UK MHRA medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
MHRA Registered
In Vitro Diagnostic Device
๐Ÿ‡ฌ๐Ÿ‡ง
Alpha-1-antitrypsin (protease inhibitor) IVD, reagent
MHRA Device ID: 134335โ€ขRef: 134335

Device Type

In Vitro Diagnostic Device

Devices

Alpha-1-antitrypsin (protease inhibitor) IVD, reagent

Type

IVD General

Date Registered

Dec 23, 2021

Last Updated

Nov 30, 2022

Manufacturer Information

Address

12779 Gateway Drive S.

Tukwila, WA, United States

Created Date

Dec 23, 2021

Authorized Representative

Relationship Type

UK Responsible Person

Address

184B Park Drive Milton Park Abingdon

Abingdon, Oxfordshire, United Kingdom

Postcode: OX14 4SE

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing